Xcell Therapeutics Inc. (KOSDAQ:373110)
South Korea
· Delayed Price · Currency is KRW 3,755.00
-115.00 (-2.97%)
Apr 28, 2025, 3:30 PM KST
Xcell Therapeutics Market Cap
Xcell Therapeutics has a market cap or net worth of 42.33 billion as of April 25, 2025.
Market Cap
42.33B
Enterprise Value
39.23B
Revenue
1.93B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,755.00
Market Cap Chart
Since July 15, 2024, Xcell Therapeutics's market cap has decreased from 90.22B to 42.33B, a decrease of -53.08%. That is a compound annual growth rate of -62.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 42.33B | -4.62% |
| Dec 30, 2024 | 44.38B | -50.80% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.67T |
| Celltrion | 33.84T |
| ALTEOGEN | 19.67T |
| Yuhan | 8,608.63B |
| SK Biopharmaceuticals | 8,081.93B |
| HLB Co., Ltd. | 7,240.39B |
| Peptron | 4,063.06B |
| LigaChem Biosciences | 4,045.44B |